Abstract
Objective:In a recently completed randomised clinical trial in patients with colorectal cancer resections the combination of the granulocyte-colony stimulating factor (G-CSF) + cefuroxime/ metronidazole (cef/met) was superior to ofloxacin/metronidazole (ofl/met). These combinations were used to confirm the clinical data and to validate the concept of clinic modelling randomised trials (CMRTs) in a rat model of intra-abdominal sepsis.
Subjects:80 male Wistar rats were randomised in a 2×2 factorial study design.
Treatment:All animals (n = 20/group) received anaesthesia, antihistamines, antibiotic prophylaxis, peritoneal contamination and infection. Groups were: 1) G-CSF+cef/met; 2) placebo+cef/ met; 3) G-CSF+ofl/met; 4) placebo+ ofl/met. G-CSF (20 g/kg) prophylaxis was applied three times.
Methods:Survival at 120 h was analysed with the Kaplan Meier method.
Results:Survival rate was best in the G-CSF+cef/met group with 75% and was significantly improved compared to the cef/met placebo group, in which only 42% survived (P < 0.05). Survival rate between both G-CSF groups was similar being 75% in the cef/met and 72% in the ofl/met group. P = 0.10). Ozone increased TNF-α and MIP-2 after infection: 127±23 pg/ml and 94±19 pg/ml (control group: 398 pg/ml and 369 pg/ml; P < 0.002 and P < 0.01). IL-6 levels were similar in both groups.
Conclusions:The results of this CMRT confirmed the result of our clinical G-CSF trial in that G-CSF prophylaxis was most efficacious in combination with cef/met to improve the outcome.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bauhofer, A., Celik, I., Plaul, U. et al. Effects of G-CSF and antibiotic prophylaxis in a 2×2 factorial design on outcome in septic rats. Inflamm. res. 53 (Suppl 2), S126–S129 (2004). https://doi.org/10.1007/s00011-004-0355-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-004-0355-4